SCHEMBL9046497

SCHEMBL9046497

COc1ccc(CCN(C)CCCN(CC2CCCC2)C(=O)C/C=C/c2ccc3c(c2)OCO3)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 14/20 0.46
HTR2B P41595 14/20 0.46
HTR2C P28335 13/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
HTR1A P08908 2/20 0.44
SLC6A4 P31645 2/20 0.44
ADRB1 P08588 1/20 0.44
ADRA2A P08913 1/20 0.44
DRD2 P14416 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
DRD1 P21728 1/20 0.44
DRD4 P21917 1/20 0.44
SLC6A2 P23975 1/20 0.44
ADRA1D P25100 1/20 0.44
HTR1D P28221 1/20 0.44
HTR7 P34969 1/20 0.44
ADRA1A P35348 1/20 0.44
HRH1 P35367 1/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8828540 0.88 HTR2A (0.49) HTR2AHTR2BHTR2CL3MBTL1HTR1A
SCHEMBL8828159 0.87 HTR2A (0.47) HTR2AHTR2BHTR2CL3MBTL1HTR1A
SCHEMBL8828324 0.87 HTR2A (0.48) HTR2AHTR2BHTR2CL3MBTL1HTR1A
SCHEMBL9044808 0.84 HTR2A (0.49) HTR2AHTR2BHTR2CL3MBTL1HTR1A
SCHEMBL8828397 0.80 L3MBTL1 (0.60) HTR2AHTR2BHTR2CL3MBTL1HTR1A
SCHEMBL9047228 0.77 TRPM8 (0.45) HTR2AHTR2BHTR2CHTR1ASLC6A4
SCHEMBL9045792 0.76 L3MBTL1 (0.53) HTR2AHTR2BHTR2CL3MBTL1OPRM1
SCHEMBL8828277 0.75 KDM4E (0.66) L3MBTL1DRD2DRD3
SCHEMBL8828377 0.75 CYP3A4 (0.50) OPRM1
SCHEMBL8828132 0.75 MAPT (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0344577-B1 Butenoic or propenoic acid derivatives EISAI CO LTD (JP) 1996-10-09 EP claimed
EP-0527081-A1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use PIERRE FABRE MEDICAMENT (FR) 1993-02-10 EP claimed
EP-0359627-A1 2,3-Dihydro-3-arylalkylaminoalkyl-4H-1,3-benzoxazin-4-one derivatives, their preparation and their use as therapeutic agents PIERRE FABRE MEDICAMENT (FR) 1990-03-21 EP claimed
EP-0527081-B1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use PF MEDICAMENT (FR) 1996-01-03 EP disclosed
EP-0527081-A1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use PIERRE FABRE MEDICAMENT (FR) 1993-02-10 EP disclosed
EP-0359627-A1 2,3-Dihydro-3-arylalkylaminoalkyl-4H-1,3-benzoxazin-4-one derivatives, their preparation and their use as therapeutic agents PIERRE FABRE MEDICAMENT (FR) 1990-03-21 EP disclosed